Pharmaceutical Grade 1190307-88-0 Sofosbuvir Pro curatio Hepatitis C
Productumnomen | Sofosbuvir |
Synonyma | N-[[P(S),2'R]-2′-Deoxy-2′-fluoro-2′-methyl-P-phenyl-5′-uridylyl]-L-alanine 1-methylethyl ester;PSI 7977 |
CAS Non. | 1190307-88-0 |
Aspectus | Album vel off-album crystallize pulveris |
Formulae hypotheticae | C22H29FN3O9P |
M. Pondus | 529.45 |
Consuetudinem | Investigationis proposito |
stipare | Quod per petitio tua |
Repono | Serva in stricta, levis vasis repugnans in loco frigido |
Sofosbuvir Cas: 1190307-88-0 | ||
Items | Standard | Proventus |
Aspectus | Album vel off-album crystallize pulveris | Obsequitur |
Lepidium sativum | Retentione tempus solutionis principalis apicem sample solutionis respondet solutioni vexillum, prout in probatione pertentare obtinetur. | Obsequitur |
Exustiopunctum | 118.0℃-128.0℃ | 121.9℃-123℃ |
Damnum in siccitate | NMT 0.5% | 0.16% |
RELICTUM in ignitio | NMT 0.2% | 0.16% |
Aquae | NMT 0.5% | 0.10% |
Puritas Chiral | Rp-isomer: NMT 0.2% | 0.01% |
Substantia cognata | Impura A: NMT 0.2%Impuritas B: NMT 0.1% Impuritas C: NMT 0.1% Alia immunditia: NMT 0.2% Totalis immunditiae: NMT 1.0% | 0.04%Non detectum Non detectum 0.04% 0.16% |
Assay | 98.0%~ 102.0% | 98.78% |
Residua solvens | Tetrahydrofuran: NMT 720ppmDichloromethane: NMT 600ppm | 0ppm0ppm |
conclusio:prosequitur cum signis in- aedibus. |
Company Information
√ Procuratio accumsan plena experientia in technicis et technicis peritissimis sectatoribus; √ Quality is always our top consideration, Strict QC system; √ 11 annos periti quadrigis venditio educendi; √ Independentes R&D lab; √ Duae officinae GMP terminus signati longi sunt; √ Divites copiarum otiosorum officinarum copia pro project nativus; √ High Efficiency working team with consistent path.Epistulam tuam hic scribe et mitte nobis